cla extreme with l-carnitine Extreme™ Softgels BPI Sports, CLA + Carnitine,
Description
Patients who develop symptoms of unexplained hyperammonemic encephalopathy while receiving valproate therapy should receive prompt treatment (including discontinuation of valproate therapy) and be evaluated for underlying urea cycle disorders (see Contraindications and Hyperammonemia and Encephalopathy Associated with Concomitant Topiramate Use as follows)
The cheeks, eyes, or entire face may be puffy in appearance and to the touch because of water retention
See supplement facts for full list of ingredients
Product Name: Copper Tripeptide-1 (GHK-Cu)
